TOP STORIES
respiratory
Yes for PBS

4 respiratory therapies get PBAC recommendations


Drugs for asthma, pulmonary artery hypertension and non-small cell lung cancer have received recommendations for PBS listing from the Pharmaceutical Benefits Advisory Committee (PBAC). At its July 2020 meeting, the PBAC recommended the following listings: Atectura Breezhaler: listing of the...

Drugs for asthma, pulmonary artery hypertension and non-small cell lung cancer have received recommendations for PBS listing from the Pharmaceutical...

Read more